TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Eql Pharma AB
Closing information (x1000 NOK)
| Closing information | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
| Turnover |
268,156
|
261,107
|
381,244 |
| Financial expenses |
5,819
|
2,383
|
2,674 |
| Earnings before taxes |
29,036
|
39,147
|
33,463 |
| EBITDA |
41,999
|
49,853
|
41,886 |
| Total assets |
379,402
|
287,008
|
221,337 |
| Current assets |
200,760
|
167,996
|
114,863 |
| Current liabilities |
164,497
|
116,509
|
91,886 |
| Equity capital |
180,409
|
155,464
|
115,025 |
| - share capital |
1,328
|
1,314
|
1,217 |
| Employees (average) |
21
|
18
|
13 |
Financial ratios
| Fiscal year | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
| Solvency |
47.6%
|
54.2%
|
52.0% |
| Turnover per employee |
12,769
|
14,506
|
29,326 |
| Profit as a percentage of turnover |
10.8%
|
15.0%
|
8.8% |
| Return on assets (ROA) |
9.2%
|
14.5%
|
16.3% |
| Current ratio |
122.0%
|
144.2%
|
125.0% |
| Return on equity (ROE) |
16.1%
|
25.2%
|
29.1% |
| Change turnover |
4,319
|
-150,528
|
214,567 |
| Change turnover % |
2%
|
-37%
|
129% |
| Chg. No. of employees |
3
|
5
|
3 |
| Chg. No. of employees % |
17%
|
38%
|
30% |
Total value of public sale
| Fiscal year | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.